Cognition Therapeutics, Inc.
USD1.42
+0.07 (+5.19%)
CEO
Lisa Ricciardi
IPO Date
2021-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.34
Prev. Close
$1.35
Day Low
$1.27
Day High
$1.45
52W Low
$0.25
52W High
$3.83
Market Cap
$0.10B
Volume
2.19M
| 10,000 |
| $1.13 |
| 20 Apr 2026 | Ricciardi Lisa | director, officer: CEO & President | P-Purchase | Acquired | 9,175 | $1.10 |
| 20 Apr 2026 | Caggiano Anthony | Chief Medical Officer | P-Purchase | Acquired | 10,000 | $1.11 |
| 18 Feb 2026 | Ricciardi Lisa | director, officer: CEO & President | F-InKind | Disposed | 5,850 | $1.12 |
| 18 Feb 2026 | Doyle John Brendan | Chief Financial Officer | F-InKind | Disposed | 1,560 | $1.12 |
| 18 Feb 2026 | Caggiano Anthony | Chief Medical Officer | F-InKind | Disposed | 4,680 | $1.12 |
| 5 Feb 2026 | Ricciardi Lisa | director, officer: CEO & President | A-Award | Acquired | 800,000 | $0.00 |
| 5 Feb 2026 | Ricciardi Lisa | director, officer: CEO & President | F-InKind | Disposed | 26,036 | $1.12 |
| 5 Feb 2026 | Ricciardi Lisa | director, officer: CEO & President | F-InKind | Disposed | 51,704 | $1.03 |